1. Home
  2. CTRI vs MNKD Comparison

CTRI vs MNKD Comparison

Compare CTRI & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTRI
  • MNKD
  • Stock Information
  • Founded
  • CTRI 1909
  • MNKD 1991
  • Country
  • CTRI United States
  • MNKD United States
  • Employees
  • CTRI N/A
  • MNKD N/A
  • Industry
  • CTRI
  • MNKD Biotechnology: Pharmaceutical Preparations
  • Sector
  • CTRI
  • MNKD Health Care
  • Exchange
  • CTRI Nasdaq
  • MNKD Nasdaq
  • Market Cap
  • CTRI 1.8B
  • MNKD 1.9B
  • IPO Year
  • CTRI 2024
  • MNKD 2004
  • Fundamental
  • Price
  • CTRI $21.86
  • MNKD $6.01
  • Analyst Decision
  • CTRI Hold
  • MNKD Buy
  • Analyst Count
  • CTRI 7
  • MNKD 6
  • Target Price
  • CTRI $18.50
  • MNKD $8.92
  • AVG Volume (30 Days)
  • CTRI 252.0K
  • MNKD 2.7M
  • Earning Date
  • CTRI 02-15-2025
  • MNKD 02-25-2025
  • Dividend Yield
  • CTRI N/A
  • MNKD N/A
  • EPS Growth
  • CTRI N/A
  • MNKD N/A
  • EPS
  • CTRI N/A
  • MNKD 0.08
  • Revenue
  • CTRI $2,585,466,000.00
  • MNKD $267,200,000.00
  • Revenue This Year
  • CTRI N/A
  • MNKD $45.45
  • Revenue Next Year
  • CTRI $4.91
  • MNKD $16.45
  • P/E Ratio
  • CTRI N/A
  • MNKD $75.81
  • Revenue Growth
  • CTRI N/A
  • MNKD 51.35
  • 52 Week Low
  • CTRI $14.47
  • MNKD $3.17
  • 52 Week High
  • CTRI $28.65
  • MNKD $7.63
  • Technical
  • Relative Strength Index (RSI)
  • CTRI N/A
  • MNKD 37.75
  • Support Level
  • CTRI N/A
  • MNKD $5.98
  • Resistance Level
  • CTRI N/A
  • MNKD $6.32
  • Average True Range (ATR)
  • CTRI 0.00
  • MNKD 0.21
  • MACD
  • CTRI 0.00
  • MNKD -0.04
  • Stochastic Oscillator
  • CTRI 0.00
  • MNKD 20.55

About CTRI Centuri Holdings Inc. Common Stock

Centuri Holdings Inc is a pure-play North American utility infrastructure services company that partners with regulated utilities to maintain, upgrade and expand the energy network that powers millions of homes and businesses. Its service offerings primarily consist of the modernization of utility infrastructure through the maintenance, retrofitting and installation of electric and natural gas distribution networks to meet current and future demands while also preparing systems for the transition to clean energy sources. They operate under two primary lines of business which includes Gas Utility Services and Electric Utility Services it is also their two reportable segments as well.

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

Share on Social Networks: